Literature DB >> 24931370

miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth.

Zhiyong Yan1, Jianpeng Wang1, Chao Wang1, Yingbing Jiao1, Weiguo Qi1, Shusheng Che2.   

Abstract

We found that miR-96 is overexpressed in glioma, and its level inversely correlates with the survival of patients. The reduction in miR-96 abundance suppresses the proliferation and colony formation of glioma cells. The tumorigenicity of U-87 MG cells is reduced by miR-96 silencing. miR-96 contributes to the activation of Wnt/β-catenin pathway in glioma cells. HMG-box transcription factor 1 (HBP-1), a Wnt/β-catenin pathway inhibitor, is suppressed by miR-96. The reactivation of Wnt/β-catenin signaling causes an increase in the proliferation of glioma cells, and a decrease in miR-96 expression. On the other hand, HBP1 silencing promotes miR-96 expression. Collectively, miR-96 contributes to the progression of glioma by enhancing the activation of the Wnt/β-catenin pathway, and the miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes the proliferation of glioma cells.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glioma; HMG-box transcription factor 1; Proliferation; Wnt/β-catenin; miR-96

Mesh:

Substances:

Year:  2014        PMID: 24931370     DOI: 10.1016/j.febslet.2014.06.017

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  miR-155 promotes the growth of osteosarcoma in a HBP1-dependent mechanism.

Authors:  Xiaohui Sun; Xiaolin Geng; Jun Zhang; Hongxing Zhao; Ying Liu
Journal:  Mol Cell Biochem       Date:  2015-02-10       Impact factor: 3.396

2.  miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.

Authors:  Libo Xu; Jiateng Zhong; Baofeng Guo; Qi Zhu; Hang Liang; Naiyan Wen; Wenjing Yun; Ling Zhang
Journal:  Tumour Biol       Date:  2016-05-11

Review 3.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

4.  Downregulation of ring-finger protein 43 in glioma associates with poor prognosis.

Authors:  Shaoyan Xi; Xinke Zhang; Huadong Chen; Zhihai Zhong; Jiabin Lu; Wanming Hu; Qiuliang Wu; Jing Zeng
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  ZNRF3 contributes to the growth of lung carcinoma via inhibiting Wnt/β-catenin pathway and is regulated by miR-93.

Authors:  Jichan Shi; Xiangao Jiang; Zhijie Yu; Guiqing He; Hongye Ning; Zhengxing Wu; Yuwei Cai; Hehe Yu; Aiqiong Chen
Journal:  Tumour Biol       Date:  2015-09-30

6.  miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway.

Authors:  Zhiyong Yan; Shusheng Che; Jianpeng Wang; Yingbing Jiao; Chao Wang; Qinghai Meng
Journal:  Tumour Biol       Date:  2015-02-12

7.  Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.

Authors:  Ulf D Kahlert; Abigail K Suwala; Katharina Koch; Manabu Natsumeda; Brent A Orr; Masanori Hayashi; Jarek Maciaczyk; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

Review 8.  The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.

Authors:  Emeline Bollaert; Audrey de Rocca Serra; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.261

9.  MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.

Authors:  Jing Hu; Tao Sun; Hui Wang; Zhengxin Chen; Shuai Wang; Lifeng Yuan; Tingyu Liu; Hai-Ri Li; Pingping Wang; Yukuan Feng; Qinhong Wang; Roger E McLendon; Allan H Friedman; Stephen T Keir; Darell D Bigner; Jeff Rathmell; Xiang-Dong Fu; Qi-Jing Li; Huibo Wang; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2016-01-11       Impact factor: 31.743

10.  Alpinetin targets glioma stem cells by suppressing Notch pathway.

Authors:  Jianpeng Wang; Zhiyong Yan; Xia Liu; Shusheng Che; Chao Wang; Weicheng Yao
Journal:  Tumour Biol       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.